ADXN
Addex Therapeutics Ltd American Depositary Shares (ADXN)
$50
About Addex Therapeutics Ltd American Depositary Shares (ADXN)
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Details
Daily high
$10.50
Daily low
$10.03
Price at open
$10.13
52 Week High
$27.90
52 Week Low
$5.00
Market cap
8.6M
Dividend yield
0.00%
Volume
6,317
Avg. volume
27,757
P/E ratio
2.40
Addex Therapeutics Ltd American Depositary Shares News
Details
Daily high
$10.50
Daily low
$10.03
Price at open
$10.13
52 Week High
$27.90
52 Week Low
$5.00
Market cap
8.6M
Dividend yield
0.00%
Volume
6,317
Avg. volume
27,757
P/E ratio
2.40